JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Progyny Inc

Gesloten

SectorGezondheidszorg

23.08 0.3

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

23.03

Max

23.37

Belangrijke statistieken

By Trading Economics

Inkomsten

4.5M

15M

Verkoop

26M

324M

K/W

Sectorgemiddelde

40.246

38.156

Winstmarge

4.647

Werknemers

675

EBITDA

7.5M

24M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+19% upside

Dividenden

By Dow Jones

Volgende Winsten

7 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-24M

2B

Vorige openingsprijs

22.78

Vorige sluitingsprijs

23.08

Nieuwssentiment

By Acuity

50%

50%

145 / 375 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Progyny Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 sep 2024, 10:30 UTC

Top Nieuws

These Stocks Are Moving the Most Today: Enphase, First Solar, Nvidia, FedEx, Progyny, Steelcase, and More -- Barrons.com

19 sep 2024, 09:20 UTC

Top Nieuws

These Stocks Are Moving the Most Today: Enphase, First Solar, Nvidia, FedEx, Progyny, Steelcase, and More -- Barrons.com

19 sep 2024, 09:08 UTC

Top Nieuws

These Stocks Are Moving the Most Today: Enphase, First Solar, FedEx, Progyny, Steelcase, and More -- Barrons.com

Peer Vergelijking

Prijswijziging

Progyny Inc Prognose

Koersdoel

By TipRanks

19% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 27.5 USD  19%

Hoogste 30 USD

Laagste 21 USD

Gebaseerd op 7 Wall Street-analisten die 12-maands prijsdoelen bieden voor Progyny Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

7 ratings

4

Buy

3

Hold

0

Sell

Technische score

By Trading Central

22.91 / 23.375Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

Bullish Evidence

Sentiment

By Acuity

145 / 375 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.